Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World

Published:2020-12 Issue:12 Volume:40 Page:7037-7043
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

GEBBIA VITTORIO,GIRLANDO ANDREA,DI GRAZIA ALFIO,FAZIO IVAN,BORSELLINO NICOLÒ,PIAZZA DARIO,SERRETTA VINCENZO,PERGOLIZZI STEFANO,PONTORIERO ANTONIO,FIRENZE ALBERTO,VALERIO MARIA ROSARIA

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of stereotactic body radiotherapy combined with systematic therapy for metastatic renal cell carcinoma: a systematic review and meta‐analysis;MedComm;2024-04-24

2. Enhanced Theranostic Efficacy of ⁸⁹Zr and ¹⁷⁷Lu-Labeled Aflibercept in Renal Cancer: A Viable Option for Clinical Practice;Molecular Pharmaceutics;2024-04-08

3. SABR for oligometastatic renal cell carcinoma;Clinical and Translational Radiation Oncology;2024-03

4. The Diagnosis and Treatment Approach for Oligo-Recurrent and Oligo-Progressive Renal Cell Carcinoma;Cancers;2023-12-17

5. Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review;Medical Oncology;2023-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP